泛催化生物材料能够干预与炎症相关的疾病干预
Xiaoyan Jiang1,2, Yu Chen1,2,3
1School of Medicine, Shanghai University, Shanghai, 200444, P. R. China. chenyuedu@shu.edu.cn.
Nanoscale horizons
|September 17, 2025
概括
泛催化生物材料为炎症性疾病 (ID) 提供了一种新的,无毒的治疗策略. 这种方法利用准备,激活和非毒性治疗 (P-A-N) 框架来解决炎症的根本原因并改善患者的治疗结果.
科学领域:
- 生物材料科学 生物材料科学
- 催化剂是一种催化剂.
- 免疫学 免疫学 免疫学
- 纳米技术 纳米技术
背景情况:
- 由于发病率和死亡率高,炎症性疾病 (ID) 构成了全球重大健康挑战.
- 目前针对ID的治疗方法有效性有限,并带有全身毒性风险.
- 失调的炎症,氧化应激和免疫失衡导致ID的逐渐组织损伤.
研究的目的:
- 审查泛催化生物材料用于炎症疾病治疗的合理设计和治疗应用.
- 为泛催化疗法引入P-A-N (制备,激活,非毒性治疗) 框架.
- 探索泛催化生物材料作为一种变革性的,无毒的治疗范式的潜力.
主要方法:
- 全催化生物材料设计和应用的系统审查.
- 将泛催化生物材料分为无机,有机和混合系统的分类.
- 各种器官系统的治疗应用的综合摘要.
主要成果:
- 通过P-A-N框架设计的泛催化生物材料,为管理炎症疾病提供了整体和无毒的方法.
- 这些材料在心血管,神经,呼吸和感官系统中已经证明了治疗潜力.
- 该审查根据成分对生物材料进行了分类,包括无机,有机和混合系统.
结论:
- 全催化生物材料代表了炎症疾病的精确管理的前沿,从有毒治疗转向无毒治疗.
- 需要进一步的研究和临床翻译来克服当前的挑战,并充分发挥这种方法的潜力.
- 催化生物材料,生物学和医学的整合为编排病理过程提供了一个多学科的策略.
相关概念视频
01:28Inflammatory Response
16.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
16.0K
01:38Inflammation
61.7K
Overview
61.7K
01:29Inflammatory Bowel Disease IV: Pharmacological Management
528
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
528
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
499
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
499
01:24Chronic Pancreatitis I: Introduction
670
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
670
01:29Chronic Pancreatitis II: Collaborative Care
315
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
315